Article info

SARS-COV-2 vaccination after stem cell transplantation for scleroderma
Free

Authors

  1. Correspondence to Dr Doron Rimar, Rheumatology, Bnei Zion Medical Centre, Haifa 33394, Israel; doronrimar{at}gmail.com
View Full Text

Citation

Rimar D, slobodin G, Paz A, et al
SARS-COV-2 vaccination after stem cell transplantation for scleroderma

Publication history

  • Received April 28, 2021
  • Accepted May 24, 2021
  • First published May 28, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.